Intana BioScience Overview
- Founded
- 2008
- Status
- Private
- Employees
- 3
- Latest Deal Type
- 2ndary - Private
- Investors
- 1
Intana BioScience General Information
Description
Developer of a drug discovery platform designed to offer customized analysis on molecular interactions. The company's platform offers customized assay development, screening, and target or hit validation using fluorescence cross-correlation spectroscopy, enabling clients to analyze the stochastic movement of fluorescently labeled molecules in an open microscopic volume element irradiated by a focused laser beam.
Contact Information
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Primary Office
- Lochhamer Str. 29a
- Martinsried
- 82152 Planegg
- Germany
+49 089 00000000
Intana BioScience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 00000 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2013 | 00000 | 00000 | Completed | Generating Revenue | |
| 1. Seed Round | 06-Jul-2009 | $909K | $909K | Completed | Generating Revenue |
Intana BioScience Patents
Intana BioScience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150132848-A1 | High complexity sirna pools | Granted | 26-Apr-2012 | 0000000000 | 0 |
| US-10407677-B2 | High complexity sirna pools | Active | 26-Apr-2012 | 0000000000 | 0 |
| EP-2214000-B1 | Use of fccs for the analysis of interaction parameters in an in vivo-like environment | Active | 30-Jan-2009 | 00000000000 | 0 |
| US-20120021942-A1 | Use of fccs for the analysis of interaction parameters in an in vivo-like environment | Abandoned | 30-Jan-2009 | 00000000000 | 0 |
| EP-2391882-A1 | Use of fccs for the analysis of interaction parameters in an in vivo-like environment | Withdrawn | 30-Jan-2009 | G01N21/6428 |
Intana BioScience Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Stefan Hannus | Co-Founder, CSO, Managing Director & Board Member | ||
| Frank Becker | Co-Founder, Managing Director & Board Member |
Intana BioScience Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Frank Becker | Intana BioScience | Co-Founder, Managing Director & Board Member | 000 0000 |
| Stefan Hannus | Intana BioScience | Co-Founder, CSO, Managing Director & Board Member | 000 0000 |
Intana BioScience Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIntana BioScience Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| European Commission | Government | 000 0000 | 000000 0 |